Akselbrad Dikla Czaczkes 4

What Happened Akselbrad Dikla Czaczkes, CEO of PolyPid Ltd. (PYPD), was granted a derivative award of 149,000 shares on July 15, 2026. The grant is recorded at an exercise/acquisition price of $4.46 per share, with a reported aggregate value of $664,540. This filing reports an acquisition (transaction code A) — not a sale.

Key Details

• Transaction date: 2026-07-15; Form 4 filed: 2026-07-17 (timely filing).
• Grant details: 149,000 derivative shares at $4.46 each; total value reported $664,540.
• Shares owned after transaction: not specified in the Form 4.
• Footnote: The award vests quarterly beginning May 11, 2026 through May 11, 2030 (footnote F1).
• Transaction type: derivative award/grant (code A). No immediate sale or cashless exercise reported.

Context This was a compensation-style derivative grant for the CEO that vests over time (quarterly through 2030). Derivative awards can be stock options or restricted stock units; the Form 4 lists this as a derivative acquisition rather than an outright open-market purchase or sale. Such grants are common for executive compensation and do not by themselves indicate intent to buy or sell shares on the open market.